Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)
CUSIP: 690469101
Q2 2017 13F Holders as of 30 Jun 2017
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 134,553,130
- Total 13F shares
- 7,991,379
- Share change
- +7,991,379
- Total reported value
- $81,779,560
- Price per share
- $10.49
- Number of holders
- 43
- Value change
- +$81,779,559
- Number of buys
- 43
Quarterly Holders Quick Answers
What is CUSIP 690469101?
CUSIP 690469101 identifies OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q3 2017
Recent filing periods for CUSIP 690469101:
Top shareholders of OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q2 2017
As of 30 Jun 2017,
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,991,379 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., JENNISON ASSOCIATES LLC, Tekla Capital Management LLC, Redmile Group, LLC, OppenheimerFunds, Inc., PRICE T ROWE ASSOCIATES INC /MD/, AMERIPRISE FINANCIAL INC, BAKER BROS. ADVISORS LP, and SPHERA FUNDS MANAGEMENT LTD..
This page lists
43
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2017 vs Q4 2025 Across Filers
Q4 2025 holders
83
Q2 2017 holders
43
Holder diff
-40
| Investor | Q4 2025 Shares | Q2 2017 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q2 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.